Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Drug Administration Schedule"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 37675
Tytuł:
The first randomized controlled trial in pediatric nephrology: the history of the International Study of Kidney Disease in Children (ISKDC).
Autorzy:
Primack WA; University of North Carolina Kidney Center, Chapel Hill, NC, USA. .
Chevalier RL; Department of Pediatrics, University of Virginia, Charlottesville, VA, USA.
Friedman A; University of Minnesota, Minneapolis, MN, USA.
Lemley KV; University of Southern California Keck School of Medicine, Los Angeles, CA, USA.
Norwood VF; Department of Pediatrics, University of Virginia, Charlottesville, VA, USA.
Schwartz GJ; University of Rochester Medical Center, Rochester, NY, USA.
Silverstein D; U.S. Food and Drug Administration, Silver Springs, MD, USA.
Kaskel F; Department of Pediatrics (Montefiore), Albert Einstein College of Medicine, Bronx, NY, USA.
Pokaż więcej
Źródło:
Pediatric nephrology (Berlin, Germany) [Pediatr Nephrol] 2023 Dec; Vol. 38 (12), pp. 3947-3954. Date of Electronic Publication: 2023 Jan 10.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Nephrotic Syndrome*/therapy
Nephrotic Syndrome*/drug therapy
Nephrology*
Kidney Diseases*/therapy
Kidney Diseases*/drug therapy
Child ; Humans ; Recurrence ; Drug Administration Schedule
Czasopismo naukowe
Szczegóły
Tytuł:
Retrospective evaluation of LCP-tacrolimus (Envarsus XR) dosing in de novo kidney transplant.
Autorzy:
Alzahrani M; Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, Illinois, USA.
Belcher RM; Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, Illinois, USA.
Benken J; Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, Illinois, USA.; Department of Surgery, College of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.
Valdepenas B 3rd; Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, Illinois, USA.
Di Cocco P; Department of Surgery, College of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.
Kajavathanan M; Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, Illinois, USA.
Benken ST; Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, Illinois, USA.
Pokaż więcej
Źródło:
Clinical transplantation [Clin Transplant] 2023 Nov; Vol. 37 (11), pp. e15082. Date of Electronic Publication: 2023 Jul 31.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Tacrolimus*
Kidney Transplantation*
Humans ; Adolescent ; Retrospective Studies ; Drug Administration Schedule ; Immunosuppressive Agents ; Obesity/drug therapy ; Obesity/surgery
Czasopismo naukowe
Szczegóły
Tytuł:
Safety and Efficacy of Conversion to Once-Daily Tacrolimus from Twice-Daily Tacrolimus in Pediatric Liver Transplant Recipients.
Autorzy:
An S; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Lee S; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. Electronic address: .
Rhu J; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Kim JM; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Choi GS; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Joh JW; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Pokaż więcej
Źródło:
Journal of pediatric surgery [J Pediatr Surg] 2023 Oct; Vol. 58 (10), pp. 2054-2058. Date of Electronic Publication: 2023 May 11.
Typ publikacji:
Journal Article
MeSH Terms:
Tacrolimus*/adverse effects
Liver Transplantation*
Humans ; Child ; Immunosuppressive Agents/therapeutic use ; Drug Administration Schedule ; Transplantation, Homologous ; Graft Rejection/prevention & control ; Delayed-Action Preparations
Czasopismo naukowe
Szczegóły
Tytuł:
Comparison of the Prolonged- and Immediate-Release Tacrolimus Capsule Formulation: The Patient's View and Medication Satisfaction of Patients After Pediatric Heart Transplantation.
Autorzy:
Paintner P; Department of Pediatric Cardiology and Intensive Care Medicine, Ludwig-Maximilians-University Munich, Munich, Germany.
Lehner A; Department of Pediatric Cardiology and Intensive Care Medicine, Ludwig-Maximilians-University Munich, Munich, Germany.
Riley R; Department of Pediatric Cardiology and Intensive Care Medicine, Ludwig-Maximilians-University Munich, Munich, Germany.
Fischer M; Department of Pediatric Cardiology and Intensive Care Medicine, Ludwig-Maximilians-University Munich, Munich, Germany.
Kozlik-Feldmann R; Department of Pediatric Cardiology, UKE Hamburg, Hamburg, Germany.
Rosenthal L; Department of Pediatric Cardiac Surgery, Ludwig-Maximilians-University Munich, Munich, Germany.
Orban M; Department of Cardiology, Ludwig-Maximilians-University Munich, Munich, Germany.
Jakob A; Department of Pediatric Cardiology and Intensive Care Medicine, Ludwig-Maximilians-University Munich, Munich, Germany.
Haas N; Department of Pediatric Cardiology and Intensive Care Medicine, Ludwig-Maximilians-University Munich, Munich, Germany.
Ulrich S; Department of Pediatric Cardiology and Intensive Care Medicine, Ludwig-Maximilians-University Munich, Munich, Germany. Electronic address: .
Pokaż więcej
Źródło:
Transplantation proceedings [Transplant Proc] 2023 Sep; Vol. 55 (7), pp. 1656-1663. Date of Electronic Publication: 2023 Jul 10.
Typ publikacji:
Journal Article
MeSH Terms:
Tacrolimus*/therapeutic use
Heart Transplantation*/adverse effects
Humans ; Child ; Adolescent ; Young Adult ; Adult ; Retrospective Studies ; Patient Satisfaction ; Drug Administration Schedule ; Immunosuppressive Agents/therapeutic use ; Personal Satisfaction
Czasopismo naukowe
Szczegóły
Tytuł:
Hepatocyte proliferation activity in untreated rats, measured by immunohistochemical detection of Ki-67: The effect of age on the repeated-dose liver micronucleus assay.
Autorzy:
Satomoto K; BoZo Research Center Inc., 1284 Kamado, Gotemba-shi, Shizuoka 412-0039, Japan. Electronic address: .
Aoki M; BoZo Research Center Inc., 1284 Kamado, Gotemba-shi, Shizuoka 412-0039, Japan.
Wakita A; BoZo Research Center Inc., 1284 Kamado, Gotemba-shi, Shizuoka 412-0039, Japan.
Yamagata H; BoZo Research Center Inc., 1284 Kamado, Gotemba-shi, Shizuoka 412-0039, Japan.
Mitsumoto T; BoZo Research Center Inc., 1284 Kamado, Gotemba-shi, Shizuoka 412-0039, Japan.
Okamoto T; BoZo Research Center Inc., 1284 Kamado, Gotemba-shi, Shizuoka 412-0039, Japan.
Harada R; ITR Laboratories Canada Inc., 19601 Clark Graham Ave, Baie-D'Urfé, Quebec H9X 3T1, Canada.
Hamada S; BoZo Research Center Inc., 1284 Kamado, Gotemba-shi, Shizuoka 412-0039, Japan.
Pokaż więcej
Źródło:
Mutation research. Genetic toxicology and environmental mutagenesis [Mutat Res Genet Toxicol Environ Mutagen] 2023 Aug-Sep; Vol. 890, pp. 503658. Date of Electronic Publication: 2023 Jul 10.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinogens*/toxicity
Bone Marrow*
Rats ; Animals ; Ki-67 Antigen ; Micronucleus Tests/methods ; Rats, Sprague-Dawley ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Administration, Oral ; Chromosome Aberrations ; Cooperative Behavior ; Societies, Pharmaceutical ; Liver ; Hepatocytes ; Cell Proliferation
Czasopismo naukowe
Szczegóły
Tytuł:
Patient-reported migraine-specific quality of life, activity impairment and headache impact with once-daily atogepant for preventive treatment of migraine in a randomized, 52-week trial.
Autorzy:
Lipton RB; Albert Einstein College of Medicine, Bronx, NY, USA.
Halker Singh RB; Mayo Clinic, Scottsdale, AZ, USA.
Mechtler L; Dent Neurologic Institute, Buffalo, NY, USA.
McVige J; Dent Neurologic Institute, Buffalo, NY, USA.
Ma J; AbbVie, Madison, NJ, USA.
Yu SY; AbbVie, Irvine, CA, USA.
Stokes J; AbbVie, Madison, NJ, USA.
Dabruzzo B; AbbVie, Madison, NJ, USA.
Gandhi P; AbbVie, Madison, NJ, USA.
Ashina M; Danish Headache Center, Rigshospitalet Glostrup, University of Copenhagen, Denmark.
Pokaż więcej
Źródło:
Cephalalgia : an international journal of headache [Cephalalgia] 2023 Aug; Vol. 51 (8), pp. 3331024231190296.
Typ publikacji:
Randomized Controlled Trial; Multicenter Study; Journal Article
MeSH Terms:
Quality of Life*
Piperidines*/administration & dosage
Piperidines*/therapeutic use
Pyridines*/administration & dosage
Pyridines*/therapeutic use
Pyrroles*/administration & dosage
Pyrroles*/therapeutic use
Spiro Compounds*/administration & dosage
Spiro Compounds*/therapeutic use
Calcitonin Gene-Related Peptide Receptor Antagonists*/administration & dosage
Calcitonin Gene-Related Peptide Receptor Antagonists*/therapeutic use
Migraine Disorders*/prevention & control
Humans ; Patient Reported Outcome Measures ; Drug Administration Schedule
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A discrete choice experiment on oral and injection treatment preferences among moderate-to-severe psoriasis patients in Japan.
Autorzy:
Komine M; Jichi Medical University Hospital, Tochigi, Shimotsuke, Japan.
Kim H; Bristol Myers Squibb, Tokyo, Japan.
Yi J; Syneos Health, Tokyo, Japan.
Zhong Y; Bristol Myers Squibb, New York, New York, USA.
Sakai Y; Syneos Health, Tokyo, Japan.
Crawford B; Syneos Health, Tokyo, Japan.
Habiro K; Bristol Myers Squibb, Tokyo, Japan.
Hikichi Y; Bristol Myers Squibb, Tokyo, Japan.
Feldman SR; Atrium Health Wake Forest Baptist, North Carolina, Winston-Salem, USA.
Pokaż więcej
Źródło:
The Journal of dermatology [J Dermatol] 2023 Jun; Vol. 50 (6), pp. 766-777. Date of Electronic Publication: 2023 Feb 20.
Typ publikacji:
Journal Article
MeSH Terms:
Choice Behavior*
Psoriasis*/drug therapy
Adult ; Humans ; Japan ; Drug Administration Schedule ; Patient Preference
Czasopismo naukowe
Szczegóły
Tytuł:
Pharmacokinetics, Safety, and Tolerability of Single-Dose Orally Administered Venglustat in Healthy Chinese Volunteers.
Autorzy:
Li Y; Translational Medicine and Clinical Pharmacology, Sanofi, Beijing, China.
Li Y; Clinical Trial Center, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Li L; Pharmacokinetics, Dynamics and Metabolism, Sanofi R&D, Shanghai, China.
Xue W; Clinical Trial Center, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Xin K; Global Research and Development, Sanofi, Chengdu, China.
Wang T; Clinical Trial Center, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Shi A; Clinical Trial Center, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China. .
Pokaż więcej
Źródło:
Clinical drug investigation [Clin Drug Investig] 2023 Jun; Vol. 43 (6), pp. 413-420. Date of Electronic Publication: 2023 Jun 03.
Typ publikacji:
Clinical Trial, Phase I; Journal Article
MeSH Terms:
Asian People*
Female ; Humans ; Male ; Administration, Oral ; Area Under Curve ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Healthy Volunteers ; Adolescent ; Young Adult ; Adult ; Middle Aged ; China ; Enzyme Inhibitors/adverse effects ; Enzyme Inhibitors/pharmacokinetics ; Enzyme Inhibitors/therapeutic use
Czasopismo naukowe
Szczegóły
Tytuł:
Comparison of prophylactic effects for chemotherapy induced neutropenia between same-day versus next-day administration of pegteograstim (Neurapeg®) in patients treated with chemotherapy regimen composed of day 1 intensive myleosuppressive agent: A randomized phase III clinical trial.
Autorzy:
Park K; Medical Oncology and Hematology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea.; Department of Internal Medicine, Hanyang University Seoul Hospital, Hanyang University College of Medicine, Seoul, Korea.
Jeon YK; Medical Oncology and Hematology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea.
Kim JH; Medical Oncology and Hematology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea.
Choi Y; Medical Oncology and Hematology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea.
Kim JJ; Medical Oncology and Hematology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea.
Oh SB; Medical Oncology and Hematology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea.
Oh SY; Medical Oncology and Hematology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea.
Hong YJ; Department of Neurology, Uijeongbu St. Mary's Hospital, Catholic University of Korea, Seoul, Korea.
Huh SJ; Department of Internal Medicine, Dong-A University College of Medicine, Busan, Korea.
Kim I; Division of Oncology, Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine, Busan, South Korea.
Shin SH; Department of Internal Medicine, Kosin University Gospel Hospital, Kosin University College of Medicine, Busan, Korea.
Pokaż więcej
Źródło:
Medicine [Medicine (Baltimore)] 2023 May 19; Vol. 102 (20), pp. e33638.
Typ publikacji:
Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:
Neutropenia*/chemically induced
Neutropenia*/prevention & control
Antineoplastic Agents*/adverse effects
Antineoplastic Combined Chemotherapy Protocols*/adverse effects
Granulocyte Colony-Stimulating Factor*/therapeutic use
Humans ; Colorectal Neoplasms/drug therapy ; Carcinoma, Neuroendocrine/drug therapy ; Drug Administration Schedule
Czasopismo naukowe
Szczegóły
Tytuł:
Envarsus XR® pharmacokinetics in adolescents post-kidney transplantation - A pilot study.
Autorzy:
ElChaki R; Division of Pediatric Nephrology, Department of Pediatrics, University of California Los Angeles, Los Angeles, California, USA.
Ettenger R; Division of Pediatric Nephrology, Department of Pediatrics, University of California Los Angeles, Los Angeles, California, USA.
Lee S; Department of Pharmaceutical Services, Ronald Reagan UCLA Medical Center, Los Angeles, California, USA.
Chen L; Department of Medicine Statistics Core, University of California Los Angeles, Los Angeles, California, USA.
Gales B; Division of Pediatric Nephrology, Department of Pediatrics, University of California Los Angeles, Los Angeles, California, USA.
Srivastava R; Division of Pediatric Nephrology, Department of Pediatrics, University of California Los Angeles, Los Angeles, California, USA.
Pearl M; Division of Pediatric Nephrology, Department of Pediatrics, University of California Los Angeles, Los Angeles, California, USA.
Pokaż więcej
Źródło:
Pediatric transplantation [Pediatr Transplant] 2023 May; Vol. 27 (3), pp. e14480. Date of Electronic Publication: 2023 Feb 02.
Typ publikacji:
Journal Article
MeSH Terms:
Tacrolimus*
Kidney Transplantation*/methods
Adult ; Humans ; Adolescent ; Child ; Immunosuppressive Agents/adverse effects ; Pilot Projects ; Bayes Theorem ; Graft Rejection/prevention & control ; Graft Rejection/drug therapy ; Drug Administration Schedule ; Delayed-Action Preparations
Czasopismo naukowe
Szczegóły
Tytuł:
Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria.
Autorzy:
Taylor WR; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, 420/60 Rajvithi Road, Bangkok, 10400, Thailand. .; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK. .
Hoglund RM; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, 420/60 Rajvithi Road, Bangkok, 10400, Thailand.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Peerawaranun P; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, 420/60 Rajvithi Road, Bangkok, 10400, Thailand.
Nguyen TN; Oxford University Clinical Research Unit, Wellcome Trust Major Oversea Programme, Ho Chi Minh City, Vietnam.
Hien TT; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Oxford University Clinical Research Unit, Wellcome Trust Major Oversea Programme, Ho Chi Minh City, Vietnam.
Tarantola A; Institut Pasteur du Cambodge, 5 Monivong Boulevard, Phnom Penh, 12201, Cambodia.
von Seidlein L; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, 420/60 Rajvithi Road, Bangkok, 10400, Thailand.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Tripura R; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, 420/60 Rajvithi Road, Bangkok, 10400, Thailand.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Department of Global Health, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Peto TJ; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, 420/60 Rajvithi Road, Bangkok, 10400, Thailand.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Dondorp AM; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, 420/60 Rajvithi Road, Bangkok, 10400, Thailand.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Landier J; Shoklo Malaria Research Unit, Mae Sot, Thailand.; Aix-Marseille Université, IRD, INSERM, SESSTIM, Marseille, France.
H Nosten F; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Shoklo Malaria Research Unit, Mae Sot, Thailand.
Smithuis F; Myanmar Oxford Clinical Research Unit, Yangon, Myanmar.
Phommasone K; Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Mahosot Hospital, Vientiane, Lao PDR.; Amsterdam Institute for Global Health & Development, Amsterdam, The Netherlands.
Mayxay M; Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Mahosot Hospital, Vientiane, Lao PDR.; Institute of Research and Education Development, University of Health Sciences, Vientiane, Lao PDR.
Kheang ST; Center for Health and Social Development (HSD), National Institute for Public Health (NIPH) and University Research Co., LLC (URC), Chey Chumneas, Daun Penh, Phnom Penh, Cambodia.; AQUITY Global Inc, 987 Avenel Farm Dr, Potomac, MD, 20854, USA.
Say C; Center for Health and Social Development (HSD), National Institute for Public Health (NIPH) and University Research Co., LLC (URC), Chey Chumneas, Daun Penh, Phnom Penh, Cambodia.
Neeraj K; University Research Co., LLC Washington DC, 7200 Wisconsin Ave, Bethesda, MD, 20814, USA.
Rithea L; National Center for Parasitology, Entomology and Malaria Control, Khan Sen Sok, Phnom Penh, Cambodia.
Dysoley L; National Center for Parasitology, Entomology and Malaria Control, Khan Sen Sok, Phnom Penh, Cambodia.; Institute of Public Health, Phnom Penh, Cambodia.
Kheng S; National Center for Parasitology, Entomology and Malaria Control, Khan Sen Sok, Phnom Penh, Cambodia.
Muth S; National Center for Parasitology, Entomology and Malaria Control, Khan Sen Sok, Phnom Penh, Cambodia.
Roca-Feltrer A; Malaria Consortium, London, UK.
Debackere M; MSF Belgium Cambodia Malaria Program, Khan Chamkarmon, Phnom Penh, Cambodia.
Fairhurst RM; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, 20852, USA.
Song N; FHI 360 Cambodia Office, Keng Kang III Khan Chamkamon, Phnom Penh, Cambodia.
Buchy P; Institut Pasteur du Cambodge, 5 Monivong Boulevard, Phnom Penh, 12201, Cambodia.; GSK Vaccines, 23 Rochester Park, Singapore, Singapore.
Menard D; Institut Pasteur du Cambodge, 5 Monivong Boulevard, Phnom Penh, 12201, Cambodia.; Unité Génétique du Paludisme Et Résistance, Département Parasites Et Insectes Vecteurs, Institut Pasteur, Paris, France.
White NJ; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, 420/60 Rajvithi Road, Bangkok, 10400, Thailand.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Tarning J; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, 420/60 Rajvithi Road, Bangkok, 10400, Thailand.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Mukaka M; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, 420/60 Rajvithi Road, Bangkok, 10400, Thailand.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Pokaż więcej
Źródło:
Malaria journal [Malar J] 2021 Sep 09; Vol. 20 (1), pp. 366. Date of Electronic Publication: 2021 Sep 09.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Administration Schedule*
Antimalarials/*administration & dosage
Malaria, Vivax/*prevention & control
Plasmodium vivax/*drug effects
Primaquine/*administration & dosage
Adolescent ; Adult ; Age Factors ; Aged ; Aged, 80 and over ; Body Weight ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Male ; Middle Aged ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Complexity of Medication Regimens for Children With Neurological Impairment.
Autorzy:
Feinstein JA; Adult and Child Consortium for Health Outcomes Research and Delivery Science, University of Colorado and Children's Hospital Colorado, Aurora.; Department of Pediatrics, University of Colorado, Aurora.
Friedman H; Pediatric Residency Program, University of Colorado, Aurora.
Orth LE; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora.
Feudtner C; Division of General Pediatrics, Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Kempe A; Adult and Child Consortium for Health Outcomes Research and Delivery Science, University of Colorado and Children's Hospital Colorado, Aurora.; Department of Pediatrics, University of Colorado, Aurora.
Samay S; Research Informatics, Analytics Resource Center, Children's Hospital Colorado, Aurora.
Blackmer AB; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora.
Pokaż więcej
Źródło:
JAMA network open [JAMA Netw Open] 2021 Aug 02; Vol. 4 (8), pp. e2122818. Date of Electronic Publication: 2021 Aug 02.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Drug Administration Schedule*
Chronic Disease/*drug therapy
Medication Adherence/*statistics & numerical data
Nervous System Diseases/*drug therapy
Adolescent ; Child ; Child, Preschool ; Cross-Sectional Studies ; Female ; Humans ; Infant ; Male ; United States
Czasopismo naukowe
Szczegóły
Tytuł:
Association of Chemotherapy Timing in Pregnancy With Congenital Malformation.
Autorzy:
van Gerwen M; Center for Gynecological Oncology Amsterdam, Antoni van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam, the Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Maggen C; Department of Oncology, KU Leuven, Leuven, Belgium.
Cardonick E; Department of Obstetrics and Gynecology, Cooper University Health Care, Camden, New Jersey.
Verwaaijen EJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
van den Heuvel-Eibrink M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Shmakov RG; National Medical Research Centre for Obstetrics, Gynaecology and Perinatology named after Academician V.I. Kulakov, Ministry of Healthcare of Russian Federation, Moscow, Russia.
Boere I; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.
Gziri MM; Department of Obstetrics, Cliniques Universitaires St Luc, Université Catholique de Louvain, Sint-Lambrechts-Woluwe, Belgium.
Ottevanger PB; Department of Medical Oncology, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands.
Lok CAR; Center for Gynecological Oncology Amsterdam, Antoni van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam, the Netherlands.; Center for Gynecological Oncology Amsterdam, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
Halaska M; University Hospital Kralovske Vinohrady, Third Medical Faculty, Charles University, Prague, Czech Republic.
Shao LT; Cooper Medical School, Rowan University, Camden, New Jersey.
Struys I; Department of Oncology, KU Leuven, Leuven, Belgium.
van Dijk-Lokkart EM; Department of Child and Adolescent Psychiatry & Psychosocial Care, Emma Children's Hospital, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
Van Calsteren K; Department of Obstetrics, University Hospitals, Leuven, Belgium.; Department of Development and Regeneration, KU Leuven, Leuven, Belgium.
Fruscio R; Department of Obstetrics and Gynecology, San Gerardo Hospital, Milan, Italy.
Zola P; Department of Surgical Sciences, University of Turin, Turin, Italy.
Scarfone G; Gynecological Oncology Unit, Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico, Ca' Granda Ospedale Maggiore Policlinico Milan, Milan, Italy.
Amant F; Center for Gynecological Oncology Amsterdam, Antoni van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Oncology, KU Leuven, Leuven, Belgium.; Center for Gynecological Oncology Amsterdam, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
Pokaż więcej
Corporate Authors:
International Network on Cancer, Infertility and Pregnancy
Źródło:
JAMA network open [JAMA Netw Open] 2021 Jun 01; Vol. 4 (6), pp. e2113180. Date of Electronic Publication: 2021 Jun 01.
Typ publikacji:
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Drug Administration Schedule*
Abnormalities, Drug-Induced/*etiology
Antineoplastic Agents/*adverse effects
Antineoplastic Agents/*therapeutic use
Fetal Development/*drug effects
Neoplasms/*drug therapy
Adolescent ; Adult ; Cohort Studies ; Female ; Gestational Age ; Humans ; Middle Aged ; Odds Ratio ; Pregnancy ; Pregnancy Trimester, First ; Pregnant Women ; Time Factors ; Young Adult
Czasopismo naukowe
Szczegóły
Tytuł:
A randomized clinical trial comparing physician-directed or fixed-dose steroid replacement strategies for incomplete dexamethasone dosing prior to docetaxel chemotherapy.
Autorzy:
Hsu T; Division of Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa, Canada.; Department of Medicine, The University of Ottawa, Ottawa, Canada.
Fergusson D; Department of Medicine, The University of Ottawa, Ottawa, Canada.; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.
Stober C; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, Canada.
Daigle K; Department of Nursing, The Ottawa Hospital and the Ottawa Hospital Cancer Centre, Ottawa, Canada.
Moledina N; Department of Nursing, The Ottawa Hospital and the Ottawa Hospital Cancer Centre, Ottawa, Canada.
Vandermeer L; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, Canada.
Pond G; Department of Oncology, McMaster University, Hamilton, Canada.
Hilton J; Division of Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa, Canada.; Department of Medicine, The University of Ottawa, Ottawa, Canada.
Hutton B; Department of Medicine, The University of Ottawa, Ottawa, Canada.; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.
Clemons M; Division of Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa, Canada. .; Department of Medicine, The University of Ottawa, Ottawa, Canada. .; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada. .; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, Canada. .
Pokaż więcej
Corporate Authors:
REaCT investigators
Źródło:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2021 Jun; Vol. 29 (6), pp. 3113-3120. Date of Electronic Publication: 2020 Oct 15.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Drug Administration Schedule*
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Dexamethasone/*therapeutic use
Docetaxel/*therapeutic use
Glucocorticoids/*therapeutic use
Premedication/*methods
Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Dexamethasone/pharmacology ; Docetaxel/pharmacology ; Female ; Glucocorticoids/pharmacology ; Humans ; Male ; Middle Aged
Czasopismo naukowe
Szczegóły
Tytuł:
Effectiveness of scheduled intravenous acetaminophen in the postoperative pain management of video-assisted thoracic surgery.
Autorzy:
Shikatani Y; Department of General Thoracic, Breast and Endocrine Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Okayama, 700-8558, Japan.
Soh J; Department of General Thoracic, Breast and Endocrine Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Okayama, 700-8558, Japan. .
Shien K; Department of General Thoracic, Breast and Endocrine Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Okayama, 700-8558, Japan.
Kurosaki T; Department of General Thoracic, Breast and Endocrine Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Okayama, 700-8558, Japan.
Ohtani S; Department of General Thoracic, Breast and Endocrine Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Okayama, 700-8558, Japan.
Yamamoto H; Department of General Thoracic, Breast and Endocrine Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Okayama, 700-8558, Japan.
Taniguchi A; Anesthesiology and Resuscitology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Okayama, Japan.
Okazaki M; Department of General Thoracic, Breast and Endocrine Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Okayama, 700-8558, Japan.
Sugimoto S; Department of General Thoracic, Breast and Endocrine Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Okayama, 700-8558, Japan.
Yamane M; Department of General Thoracic, Breast and Endocrine Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Okayama, 700-8558, Japan.
Oto T; Department of General Thoracic, Breast and Endocrine Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Okayama, 700-8558, Japan.
Morimatsu H; Anesthesiology and Resuscitology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Okayama, Japan.
Toyooka S; Department of General Thoracic, Breast and Endocrine Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Okayama, 700-8558, Japan.
Pokaż więcej
Źródło:
Surgery today [Surg Today] 2021 Apr; Vol. 51 (4), pp. 589-594. Date of Electronic Publication: 2020 Sep 02.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Administration Schedule*
Acetaminophen/*administration & dosage
Analgesics, Non-Narcotic/*administration & dosage
Pain, Postoperative/*drug therapy
Pain, Postoperative/*etiology
Pneumonectomy/*adverse effects
Thoracic Surgery, Video-Assisted/*adverse effects
Female ; Humans ; Infusions, Intravenous ; Male ; Pneumonectomy/methods ; Retrospective Studies ; Safety ; Thoracic Surgery, Video-Assisted/methods ; Treatment Outcome
Czasopismo naukowe
Szczegóły
Tytuł:
Bisphosphonate Drug Holidays in Primary Care: When and What to Do Next?
Autorzy:
Bauer DC; University of California, San Francisco, 1545 Divisadero, 3rd floor, San Francisco, CA, 94143, USA. .
Abrahamsen B; University of Southern Denmark, Odense, Denmark.
Pokaż więcej
Źródło:
Current osteoporosis reports [Curr Osteoporos Rep] 2021 Apr; Vol. 19 (2), pp. 182-188. Date of Electronic Publication: 2021 Feb 02.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Drug Administration Schedule*
Primary Health Care*
Bone Density Conservation Agents/*administration & dosage
Osteoporosis/*drug therapy
Humans
Czasopismo naukowe
Szczegóły
Tytuł:
Population pharmacokinetics of riociguat in a pediatric population (aged ≥ 6 years) with pulmonary arterial hypertension.
Autorzy:
Willmann S; Clinical Pharmacometrics, Bayer AG, Wuppertal, Germany.
Keller AK; Clinical Pharmacometrics, Bayer AG, Wuppertal, Germany.
Meyer M; Clinical Pharmacometrics, Bayer AG, Wuppertal, Germany.
van der Mey D; Clinical Pharmacology, Bayer AG, Wuppertal, Germany.
Wirsching G; Medical Affairs & Pharmacovigilance, Bayer AG, Berlin, Germany.
Zhang Y; Clinical Pharmacometrics, Bayer AG, Wuppertal, Germany.
Drenth HJ; LAP&P Consultants, Leiden, The Netherlands.
Keunecke A; LAP&P Consultants, Leiden, The Netherlands.
Vendel E; LAP&P Consultants, Leiden, The Netherlands.
Saleh S; Clinical Pharmacology, Bayer AG, Wuppertal, Germany.
Pokaż więcej
Źródło:
Pediatric pulmonology [Pediatr Pulmonol] 2023 Mar; Vol. 58 (3), pp. 908-917. Date of Electronic Publication: 2022 Dec 28.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Pulmonary Arterial Hypertension*/drug therapy
Hypertension, Pulmonary*/drug therapy
Adult ; Adolescent ; Humans ; Child ; Treatment Outcome ; Familial Primary Pulmonary Hypertension/drug therapy ; Drug Administration Schedule
Czasopismo naukowe
Szczegóły
Tytuł:
Reduced- vs full-dose BCG in bladder cancer: A systematic review and meta-analysis.
Autorzy:
Verri P; Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Barcelona, Spain; Department of Oncology, Division of Urology, University of Turin, San Luigi Gonzaga Hospital, Orbassano (Turin), Italy. Electronic address: .
Baboudjian M; Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Barcelona, Spain; Department of Urology, APHM, North Academic Hospital, Marseille, France; Department of Urology, La Croix du Sud Hôpital, Quint Fonsegrives, France. Electronic address: .
Diana P; Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Barcelona, Spain; Department of Urology, Humanitas Clinical and Research Center-IRCCS, Rozzano, Italy. Electronic address: .
Gallioli A; Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Barcelona, Spain. Electronic address: .
Territo A; Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Barcelona, Spain. Electronic address: .
Gaya JM; Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Barcelona, Spain. Electronic address: .
Huguet J; Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Barcelona, Spain. Electronic address: .
Rodriguez-Faba O; Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Barcelona, Spain. Electronic address: .
Palou J; Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Barcelona, Spain. Electronic address: .
Breda A; Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Barcelona, Spain. Electronic address: .
Pokaż więcej
Źródło:
Actas urologicas espanolas [Actas Urol Esp (Engl Ed)] 2023 Jan-Feb; Vol. 47 (1), pp. 4-14. Date of Electronic Publication: 2022 Aug 05.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:
Adjuvants, Immunologic*/therapeutic use
Adjuvants, Immunologic*/adverse effects
Urinary Bladder Neoplasms*/pathology
Humans ; Administration, Intravesical ; Neoplasm Recurrence, Local/epidemiology ; Drug Administration Schedule
Czasopismo naukowe
Szczegóły
Tytuł:
Multiple-ascending doses of ACT-1014-6470, an oral complement factor 5a receptor 1 (C5a 1 receptor) antagonist: Tolerability, pharmacokinetics and target engagement.
Autorzy:
Anliker-Ort M; Department of Clinical Pharmacology, Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland.; Paediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel (UKBB), University of Basel, Basel, Switzerland.
Dingemanse J; Department of Clinical Pharmacology, Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland.
Farine H; Translational Biomarkers, Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland.
Groenen P; Translational Biomarkers, Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland.
Kornberger R; Parexel International GmbH, Berlin, Germany.
van den Anker J; Paediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel (UKBB), University of Basel, Basel, Switzerland.
Kaufmann P; Department of Clinical Pharmacology, Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland.
Pokaż więcej
Źródło:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2023 Jan; Vol. 89 (1), pp. 380-389. Date of Electronic Publication: 2022 Sep 07.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Factor Va*
Matrix Metalloproteinase 9*
Female ; Humans ; Male ; Administration, Oral ; Area Under Curve ; Dose-Response Relationship, Drug ; Double-Blind Method ; Drug Administration Schedule ; Healthy Volunteers
Czasopismo naukowe
Szczegóły
Tytuł:
Re: The budget impact of enzyme replacement therapy in type 1 gaucher disease in the United States.
Autorzy:
Rochmann C; Sanofi, Paris, France.
Fournier M; Sanofi, Paris, France.
Hull J; Sanofi, Cambridge, MA, USA.
Perichon M; Sanofi, Cambridge, MA, USA.
Pulikottil-Jacob R; Sanofi, Reading, United Kingdom of Great Britain and Northern Ireland.
Pokaż więcej
Źródło:
Journal of medical economics [J Med Econ] 2023 Jan-Dec; Vol. 26 (1), pp. 627-629.
Typ publikacji:
Journal Article; Comment
MeSH Terms:
Gaucher Disease*/drug therapy
Humans ; United States ; Enzyme Replacement Therapy ; Drug Administration Schedule ; Treatment Outcome
Czasopismo naukowe
Szczegóły
Wyświetlanie 1-20 z 37675

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies